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mapped by cryo-electron microscopy
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1Department of Chemistry, University of California, Berkeley, Berkeley, United
States; 2Department of Molecular and Cell Biology, University of California,
Berkeley, Berkeley, United States; 3Graduate Group in Biophysics, University of
California, Berkeley, Berkeley, United States; 4Molecular Biophysics and Integrated
Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, United States;
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Abstract Soluble guanylate cyclase (sGC) is the primary receptor for nitric oxide (NO) in
mammalian nitric oxide signaling. We determined structures of full-length Manduca sexta sGC in
both inactive and active states using cryo-electron microscopy. NO and the sGC-specific stimulator
YC-1 induce a 71˚ rotation of the heme-binding b H-NOX and PAS domains. Repositioning of the b
H-NOX domain leads to a straightening of the coiled-coil domains, which, in turn, use the motion to
move the catalytic domains into an active conformation. YC-1 binds directly between the b H-NOX
domain and the two CC domains. The structural elongation of the particle observed in cryo-EM was
corroborated in solution using small angle X-ray scattering (SAXS). These structures delineate the
endpoints of the allosteric transition responsible for the major cyclic GMP-dependent physiological
effects of NO.
DOI: https://doi.org/10.7554/eLife.50634.001
Introduction
Nitric oxide (NO) is a critical primary signaling molecule in eukaryotic organisms (Palmer et al.,
1987; Moncada et al., 1991). Cells detect this diatomic gas through the NO receptor soluble gua-
nylate cyclase (sGC), which is activated by NO to catalyze the cyclization of 50-guanosine triphos-
phate (GTP) to 30,50-cyclic guanosine monophosphate (cGMP) (Arnold et al., 1977; Stone and
Marletta, 1994; Russwurm and Koesling, 2004; Derbyshire and Marletta, 2012; Montfort et al.,
2017; Horst and Marletta, 2018). The NO signaling pathway, with sGC as a central component,
plays crucial roles in the cardiovascular and neurological systems in mammals (Lucas et al., 2000;
Prast and Philippu, 2001; Benarroch, 2011). Furthermore, aberrations in these signaling pathways
can lead to pathologies that include various forms of hypertension, cardiovascular disease, and neu-
rodegeneration (Bredt, 1999; Friebe and Koesling, 2009; Lundberg et al., 2015; Herve´ et al.,
2014; Wallace et al., 2016).
sGC is a heterodimer composed of two subunits, denoted a and b, that are each composed of
four domains: an N-terminal heme nitric oxide/oxygen (H-NOX) domain, a Per/Arnt/Sim (PAS)-like
domain, a coiled-coil (CC) domain, and a catalytic (CAT) domain (Derbyshire and Marletta, 2012;
Montfort et al., 2017). Although each subunit contains an H-NOX domain, only the b H-NOX
domain binds a heme cofactor, with direct ligation occurring through a conserved histidine residue
(Zhao et al., 1998). The CC domains, together with the PAS domains, are thought to form a
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structured assembly upon dimerization of sGC (Campbell et al., 2014). The CAT domains form a
wreath-like structure with the active site at the dimer interface (Derbyshire and Marletta, 2012;
Hurley, 1998).
Biochemical aspects of sGC activation by NO have been studied in great detail. Without a ligand
bound to the b H-NOX domain, sGC has a low basal activity. A stoichiometric equivalent of NO rela-
tive to the sGC heterodimer results in the cleavage of the proximal histidine-iron bond and the for-
mation of a distal five-coordinate ferrous nitrosyl enzyme with 15% of maximal activity
(Russwurm and Koesling, 2004; Cary et al., 2005; Fernhoff et al., 2009; Herzik et al., 2014). This
low-activity state of sGC will be referred to here as the 1-NO state; importantly, the KD of the ferrous
nitrosyl heme is 1.2  10–12 M thus in this state NO remains bound to the heme (Zhao et al., 1999).
The activity of the 1-NO state can be increased to a maximally active state either by the addition of
excess NO (xsNO), or by addition of small-molecule stimulators (Stasch et al., 2011). The benzylin-
dazole compound YC-1 was the first reported small-molecule sGC stimulator (Ko et al., 1994). It
was identified in a screen of compounds that inhibit platelet aggregation, one of the physiological
responses of sGC activation. The molecular mechanisms by which NO and small molecule stimulator
binding leads to enzyme activation remain unclear, despite the fact that the sGC-targeted drug
Adempas discovered through a small molecule screen based on the YC-1 scaffold was approved by
the FDA in 2013.
Visualization of the molecular steps in sGC activation has been a longstanding challenge. Crystal
structures of individual truncated domains from various homologues of sGC have been reported
(Pellicena et al., 2004; Purohit et al., 2013; Ma et al., 2010; Winger et al., 2008). Additionally,
structures of related heterodimeric and multidomain proteins have provided insight into the higher
order connectivity of sGC. The heterodimeric catalytic domain from Homo sapiens was solved in an
inactive conformation (Allerston et al., 2013; Seeger et al., 2014). Structures of membrane-bound
adenylate cyclases have been solved that contain catalytic domains as well as portions of or the
eLife digest In humans and other animals, as the heart pumps blood around the body, the
blood exerts pressure on the walls of the blood vessels, much like water flowing through a hose.
Our blood pressure naturally varies over the day, generally increasing when we are active and
decreasing when we rest. However, if blood pressure remains high for extended periods of time it
can lead to heart attacks, strokes and other serious health conditions.
In 2013, a new drug known as Adempas was approved to treat high blood pressure in the lungs.
This drug helps a signaling molecule in the body called nitric oxide to activate an enzyme that
widens blood vessels and in turn lower blood pressure. Previous studies have found that the enzyme
– called soluble guanylate cyclase (sGC) – contains several distinct domains and that nitric oxide
binds to a domain known as b H-NOX. However, it was not clear how b H-NOX and the other three
domains fit together to make the three-dimensional structure of the enzyme, or how nitric oxide and
Adempas activate it.
To address this question, Horst, Yokom et al. used a technique called cryo-electron microscopy
to determine the three-dimensional structures of the inactive and active forms of a soluble guanylate
cyclase from a moth known as Manduca sexta. To produce the active form of the enzyme, soluble
guanylate cyclase was incubated with both nitric oxide and a molecule called YC-1 that works in
similar way to Adempas. The structures revealed that nitric oxide and YC-1 caused b H-NOX and
another domain to rotate by 71. This in turn caused the remaining two domains – known as the
coiled-coil domains – to change shape, and all of these movements together led to the activated
enzyme. The structures also revealed that YC-1 bound to a site on the enzyme between b H-NOX
and the coiled-coil domains.
Understanding how a drug for a particular condition works makes it much easier to develop new
drugs that are more effective at treating the same condition or are tailored to treat other diseases.
Therefore, these findings will allow pharmaceutical companies and other organizations to develop
new drugs for high blood pressure and other cardiovascular diseases in a much more precise way.
DOI: https://doi.org/10.7554/eLife.50634.002
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entire CC domains, helping to orient the C-terminal domains of sGC (Vercellino et al., 2017;
Qi et al., 2019). However, the precise quaternary structural arrangement of domains in the N-termi-
nal portion of sGC is not known. Consequently, the mechanism by which NO and small-molecule
stimulators couple binding through the protein for activation are poorly understood.
In the absence of a high-resolution full-length structure, previous work has used alternative meth-
ods in attempts to understand interdomain interactions and how small molecules activate sGC.
Crosslinking experiments and negative stain electron microscopy support the hypothesis that sGC is
a flexible dumbbell-shaped particle, in which the CC domains serve to connect the H-NOX and PAS
domains on one end of the dumbbell to the CAT domain on the other (Campbell et al., 2014;
Fritz et al., 2013). Hydrogen deuterium exchange mass spectrometry (HDX-MS) has implicated the
linker region between the PAS domains and the CC domains as critical in the activation mechanism,
as both regions change in H/D exchange upon NO binding to sGC (Underbakke et al., 2014). Trun-
cations of sGC have suggested that the b H-NOX domain directly inhibits the CAT domains
(Winger and Marletta, 2005). Point mutagenesis was used to identify several residues thought to
transmit the ligand occupancy of the gas-binding H-NOX domain to the catalytic domains, including
b D102 and b D106 (Baskaran et al., 2011a; Underbakke et al., 2013). None of these methods,
however, afford sufficient resolution to discern domain organization and interdomain communication
for the full-length protein.
Here, we report the first full-length structures of sGC with and without activating ligands using
cryoelectron microscopy (cryo-EM) to 5.1 and 5.8 A˚ resolution, respectively. We find that sGC
adopts two dramatically different conformations, revealing a large-scale global conformational
change in response to NO and YC-1. Density consistent with YC-1 is observed in the active state
map directly between the b H-NOX and both CC domains. We also show the functional relationship
of NO binding to sGC on overall organization of sGC in solution by small angle X-ray scattering
(SAXS). By visualizing the quaternary structural changes that activate this NO receptor, we can now
answer the long-standing question as to how the ligand binding in the regulatory domains of sGC is
communicated to the catalytic domains.
Results
Characterization and activity of full-length Manduca sexta sGC
We selected Manduca sexta (Ms) sGC as a biochemically tractable protein which has 36% and 59%
sequence identity when compared to the human homolog for the a and b monomers, respectively.
A schematic of the domain organization is shown in Figure 1a. Additionally, the regulatory proper-
ties in response to NO and YC-1 mirror those of its human counterpart and YC-1 had been shown to
increase the Ms sGC 1-NO state to maximal activity (Hu et al., 2008). While full-length Ms sGC has
only been previously reported to be expressed in E. coli, we used a baculoviral expression protocol
to produce reliable quantities of stable, full-length protein (Figure 1—figure supplements 1 and
2) (Hu et al., 2008). UV–visible absorption spectra of Ms sGC without ligands (unliganded, U), with
xsNO, and with carbon monoxide (CO) show the expected ligand-dependent shifts of the Soret and
Q bands, indicating the b H-NOX domain is competent to bind diatomic gases (Figure 1b).
We confirmed that Ms sGC displays catalytic activity similar to other well-characterized mamma-
lian homologues, including Homo sapiens sGC. Ms sGC exhibits a low, basal activity in the unli-
ganded state (71 ± 36 nmol/min/mg) and partial activation in the 1-NO state (309 ± 77 nmol/min/
mg) (Figure 1c, Figure 1—figure supplement 3), consistent with previous reports of mammalian
sGCs (Fernhoff et al., 2009). Maximal activity could be achieved by adding excess NO to the 1-NO
sample (1988 ± 131 nmol/min/mg), or by the addition the sGC stimulator YC-1 to the 1-NO state
(1522 ± 38 nmol/min/mg) (Figure 1c, Figure 1—figure supplement 4). Taken together, Ms sGC dis-
plays biochemical properties comparable to well-characterized mammalian sGCs.
Inactive conformation of sGC exhibits bent coiled-coils
Cryo-EM was used to solve the structure of full-length inactive Ms sGC. Two-dimensional classifica-
tion after removing poor particles showed intact density with two lobes with connective density
between them similar to previously reported EM envelopes obtained by negative stain (Figure 2—
figure supplements 1–3) (Campbell et al., 2014). Three-dimensional classification and refinement
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Figure 1. Domain arrangement and activation of Manduca sexta (Ms) soluble guanylyl cyclase (sGC). (a) Schematic representation of the Ms sGC
heterodimer domain architecture. sGCs contain four domains: a heme nitric oxide/oxygen (H-NOX) binding domain, a Per/Arnt/Sim (PAS)-like domain,
a coiled-coil (CC) domain, and a catalytic cyclase domain (CAT). The heme binding site in b H-NOX is represented by the gray quadrilateral. (b) UV–
visible absorption spectra of Ms sGC in the unliganded (U), NO-bound, and CO-bound states. The wavelength maxima of the Soret peaks are
indicated. Inset: Q bands show increased splitting upon gas binding. (c) Discontinuous cGMP activity assay for Ms sGC with various activation
conditions: 1-NO, xsNO, and YC-1 ligands. Initial rates were taken from assays run at 25˚C, pH 7.5 with 2 mM Mg.GTP as the substrate (see Figure 1—
figure supplement 1b). cGMP formation was measured using an enzyme linked immunosorbent assay. The average initial rate is plotted, and the error
bars reflect one standard deviation (n = 4).
DOI: https://doi.org/10.7554/eLife.50634.003
The following source data and figure supplements are available for figure 1:
Source data 1. Source Data for UV-Visible Absorption of Ms sGC.
DOI: https://doi.org/10.7554/eLife.50634.009
Source data 2. Source Data for Activity Assays for Ms sGC.
DOI: https://doi.org/10.7554/eLife.50634.010
Figure supplement 1. Representative SDS-PAGE gels for purification of Ms sGC.
DOI: https://doi.org/10.7554/eLife.50634.004
Figure supplement 2. Deconvoluted intact protein mass spectrum of purified Ms sGC.
DOI: https://doi.org/10.7554/eLife.50634.005
Figure supplement 3. UV–visible absorption spectra of Ms sGC used in activity assays.
DOI: https://doi.org/10.7554/eLife.50634.006
Figure supplement 4. Representative time courses of the cGMP assay for Ms sGC in different ligation states.
DOI: https://doi.org/10.7554/eLife.50634.007
Figure supplement 5. Topology diagram of b H-NOX secondary structure.
DOI: https://doi.org/10.7554/eLife.50634.008
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yielded a single reconstruction with a 5.1 A˚ nominal resolution (Figure 2—figure supplement 4)
that exhibited a clear dimer interface and distinct CCs (Figure 2a, Supplementary file 1 - Table 1).
While particles display a slight orientation preference, local resolution is uniform throughout the
density map (Figure 2—figure supplements 5 and 6). Additionally, the overall map exhibits well-
defined helices and continuous density. The two lobes of the structure are termed the ‘regulatory’
lobe and the ‘catalytic’ lobe, with the CC domains acting as a bridge between them (Figure 2a). The
long axis of the regulatory lobe is positioned perpendicular to the catalytic lobe and is predicted to
contain the H-NOX/PAS bundle, while the CAT domains are predicted to form the catalytic lobe
(Campbell et al., 2014).
Several features enabled conclusive assignment of the a and b subunit domains in the density
map, despite the intermediate resolution and pseudosymmetry between the two subunits
(Figure 2b, Video 1). A rigid body global search of potential H-NOX positions revealed two possible
positions for H-NOX domains within the regulatory lobe (Pettersen et al., 2004). The aF helix of the
b H-NOX domain (Figure 1—figure supplement 5) binds a heme cofactor while the a H-NOX does
not. Only the position closest to the catalytic lobe contains density for the heme cofactor
(Figure 2c), hence this was assigned to the b subunit. The two CAT domains could be differentiated
because the a CAT domain contains a C-terminal extension (residues 661–699) which is absent in
the b CAT domain. Only one of the domains in the catalytic lobe contains extra C-terminal density
and thus the CAT domains could be assigned unambiguously (Figure 2—figure supplement 7).
Connective density from the CAT domains enabled clear differentiation of the two CC and PAS
domains (Figure 2d, green). As a result, the a PAS is assigned as the top domain, while b is the bot-
tom domain (Figure 2b). Homology models for Ms sGC domains were combined representing resi-
dues a 51–250, 279–699 and b1–183, 205–597 to create a full-length model (described in
Materials and methods).
The CC domains are in a parallel orientation, and both domains have a clear bend, distinct from a
previously determined CC X-ray structure (Ma et al., 2010). A linker extends from the C-terminus of
the PAS domains and forms a rigid loop connecting the bent helix to the H-NOX/PAS domains
(Figure 2d, light and dark green). The CC density bends sharply at residues a A422 and b L343. This
bent region forms a buried helix, and along with the C-terminal PAS linker, creates an interaction
nexus between the H-NOX, PAS, and CC domains (Figure 2d, highlighted in light and dark purple).
The bent N-terminal portion of the CC domains (a 403–415 and b 333–345), is highly conserved
across sGC homologues (Figure 2—figure supplement 8).
The CAT dimer displays a wreath-like fold with the monomers related by a twofold axis, typical
for class III nucleotide cyclase domains (Hurley, 1998; Zhang et al., 1997). The CAT domains align
well with a previous structure of an inactive guanylate cyclase (Ca RMSD of 1.3 A˚ to PDB ID: 4NI2),
displaying an inaccessible nucleotide-binding pocket that would require a significant rearrangement
for activation (Figure 2—figure supplement 9). In the absence of a substrate-bound structure of a
guanylate cyclase, we compared our model to a substrate-bound adenylate cyclase. The alignment
of the a chain of an active adenylate cyclase structure (PDB ID: 1CJK, gray) with the a CAT domain
of our inactive Ms sGC structure reveals that the Ca of b N538 from the b CAT domain is within 2 A˚
of the bound nucleotide analog in the adenylate cyclase structure (Figure 2e). This state is thus in a
closed conformation that is sterically incompatible with nucleotide binding, explaining the lack of
guanylate cyclase activity.
Activated sGC extends the regulatory lobe from catalytic core
To elucidate conformational changes associated with sGC activation, a structure of sGC bound to
NO and the small molecule stimulator YC-1 was determined. We elected to supplement the xsNO
Ms sGC with YC-1 to generate the most stable activated conformation. Particles of active Ms sGC
were well-dispersed in vitreous ice (Figure 3—figure supplements 1 and 2). Cleaned two-dimen-
sional class averages exhibit a two-lobed density that is distinct from the inactive structure (Fig-
ure 3—figure supplement 3). The final 3D reconstruction of the active state at 5.8 A˚ resolution
displays clear density for the CCs, b H-NOX, and a helices throughout the structure (Figure 3a,
Video 2, Figure 3—figure supplements 4–6). Only diffuse density was present for the a H-NOX,
likely due to increased flexibility of this domain and it was thus omitted in the model (Figure 3b).
The orientation of the domains in the regulatory lobe is maintained from the inactive state to the
active state, and the b H-NOX position is readily identified via the bound heme cofactor density
Horst et al. eLife 2019;8:e50634. DOI: https://doi.org/10.7554/eLife.50634 5 of 25
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Figure 2. Inactive Ms sGC forms a bent coiled-coil structure. (a) Views of cryo-EM density for the inactive state, colored by subunit (a - orange, b -
blue). Dimensions of the complex are shown in black. The two lobes of the enzyme are denoted ‘regulatory’ and ‘catalytic’. (b) Molecular model of Ms
sGC with domains labeled and colored as in Figure 1a. The heme is colored gray. (c) Two views of the b H-NOX domain with heme shown in gray and
H105 in red (d) View of the bent coiled-coil (purple) and PAS linker (green) shown in shades for the a (dark) and b (light) dimer. Closeup shows
connective density between the PAS and CC domains (threshold 12s). The sequences of the bent CC domains are shown below. (e) View of the inactive
catalytic dimer fit into density (a - orange, b - blue). Close up shows aligned active adenylyl cyclase (a CAT domain) and nucleotide in gray (PDB: 1CJK)
compared with the inactive sGC model. The distance between the substrate analogue and nearest backbone Ca (b N538) is shown.
DOI: https://doi.org/10.7554/eLife.50634.011
The following figure supplements are available for figure 2:
Figure supplement 1. Representative micrograph with inlet of corresponding FFT.
DOI: https://doi.org/10.7554/eLife.50634.012
Figure supplement 2. Electron microscopy flowchart for processing of inactive.
DOI: https://doi.org/10.7554/eLife.50634.013
Figure supplement 3. Selected 2D class averages.
DOI: https://doi.org/10.7554/eLife.50634.014
Figure supplement 4. FSC curve from cryosparc2 with gold standard 0.143 FSC shown in blue.
DOI: https://doi.org/10.7554/eLife.50634.015
Figure supplement 5. Plot of single particle population based on orientation parameters.
DOI: https://doi.org/10.7554/eLife.50634.016
Figure supplement 6. Inactive reconstruction colored by local resolution calculated using cryosaprc2 implementation of blocres.
Figure 2 continued on next page
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(Figure 3c). A triangular-shaped lobe of unassigned density is present in the active state map but
not in the inactive state map (Figure 3c, arrow). This density is located directly between the b
H-NOX domain and the a and b CC domains, adjacent to either the A or B pyrrole of the heme
(opposite of the propionate chains). The volume likely corresponds to YC-1 (304.3 Da) and with the
current resolution two orientations of this small molecule are possible (Figure 3c). Residues within 5
A˚ of the density include a CC 422–427 (AQDGLR), and b V39, F77, C78, Y112, and Q349.
Although the density for the b H-NOX and PAS domains is similar between the inactive and active
states, the overall shape of the molecule is more linear (Figure 3b). Continuous, linear helices from a
L406–L457 and b A333–Y386 are seen in the active state (Figure 3d, highlighted in purple). This con-
formation is more aligned with predicted CC length and is more similar to the previously published
crystal structures in terms of the range of residues seen in an unbent coiled-coil (Ma et al., 2010;
Qi et al., 2019).
The CAT heterodimer in the active state still forms a wreath-like geometry, but with the two
monomers moved apart from one another roughly perpendicular to the CC domain axis (Figure 3e).
An alignment of the a chain of an active adenylate cyclase structure (PDB ID: 1CJK, gray) with the a
CAT domain of our active Ms sGC structure shows the Ca of b N538 is now greater than 4 A˚ from
the bound nucleotide analog, providing sufficient space for the nucleotide to bind in the active site.
The Ms sGC CAT domain thus adopts an open conformation with the apparent capacity to bind
substrate.
Allosteric conformational rearrangement of sGC
Binding of NO to b H-NOX initiates the signal transduction event, thus interfaces were examined
between the inactive and active states. A significant rearrangement of the quaternary structure of
Ms sGC occurs upon activation with the regula-
tory domain rotating 71˚ and the catalytic
domain rotating 40˚ (Figure 4a, Video 3). In
both inactive and active states, the b H-NOX
domain is the closest domain of the regulatory
lobe to the CAT domains (Figure 4a); however,
in neither model does the b H-NOX domain
come into direct contact with the CAT domains.
In the inactive state, the Ca of b I47 is 12 A˚
away from the Ca of b H399 (Figure 4a, gray),
too far for direct contact. The closest Ca-Ca dis-
tance of residues between the b H-NOX domain
and the CAT domains in the active state is
between b M33 and a W468 at 21 A˚ (Figure 4a,
black), remaining too far for direct contact
between the b H-NOX and the CAT dimer.
Therefore, allosteric communication is
Figure 2 continued
DOI: https://doi.org/10.7554/eLife.50634.017
Figure supplement 7. Closeup view of the modeled inactive.
DOI: https://doi.org/10.7554/eLife.50634.018
Figure supplement 8. The coiled-coil domain of eight sequences from four heterodimeric biochemically verified NO-responsive sGCs and five
sequences from atypical sGCs that sense O2 are aligned, with conserved residues are highlighted in blue.
DOI: https://doi.org/10.7554/eLife.50634.020
Figure supplement 9. Overlay of the PDB: 4NI2 (gray) and the inactive CAT dimer (colored by a and b).
DOI: https://doi.org/10.7554/eLife.50634.019
Figure supplement 10. Inactive model of Ms sGC is shown with the bent helix in purple and the S-helix in red.
DOI: https://doi.org/10.7554/eLife.50634.021
Video 1. Cryo EM Reconstruction of the Inactive sGC
Confromation.
DOI: https://doi.org/10.7554/eLife.50634.022
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Figure 3. Active Ms sGC forms an elongated structure. (a) Views of cryo-EM density for the active state, colored by subunit (a - orange, b - blue).
Dimensions of the complex are shown in black. (b) Molecular model of Ms sGC colored as in Figure 1a. The heme is colored gray. The a H-NOX
domain is not shown due to lack of density. (c) View of the b H-NOX domain with heme shown in gray and b H105 in red. Two fits for the stimulator,
YC-1, are shown in purple (d) Model of the extended coiled-coil region (purple), highlighting the PAS linker region (green) shown in shades for the a
(dark) and b (light) dime. The sequences of the bent CC region are shown below. (e) View of active catalytic dimer (a - orange, b - blue) shown fit into
the reconstruction density. Closeup shows aligned active adenylate cyclase structure (PDB: 1CJK) with bound nucleotide (gray). The distance between
the substrate analogue and Ca of the b N538 is shown.
DOI: https://doi.org/10.7554/eLife.50634.023
The following figure supplements are available for figure 3:
Figure supplement 1. Representative micrograph with inlet of corresponding FFT.
DOI: https://doi.org/10.7554/eLife.50634.024
Figure supplement 2. Electron microscopy flowchart for processing of active sGC data.
DOI: https://doi.org/10.7554/eLife.50634.025
Figure supplement 3. Selected 2D class averages.
DOI: https://doi.org/10.7554/eLife.50634.026
Figure supplement 4. FSC curve from cryosparc2 with gold standard 0.143 FSC shown in blue.
DOI: https://doi.org/10.7554/eLife.50634.027
Figure supplement 5. Plot of single particle population based on orientation parameters.
DOI: https://doi.org/10.7554/eLife.50634.028
Figure supplement 6. Active reconstruction colored by local resolution calculated using cryosaprc2 implementation of blocres.
DOI: https://doi.org/10.7554/eLife.50634.029
Figure 3 continued on next page
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transmitted through changes in CC positioning, not through direct H-NOX:CAT interactions.
Interaction surfaces, defined by a  10 A˚ Ca to Ca distance (Donald et al., 2011), occur between
the b H-NOX and the PAS or CC region in both inactive and active states (Figure 4b,c). In the inac-
tive state, the aE, aF, and b2 secondary structural elements of the b H-NOX (82–126, green) form an
extensive interface with the b PAS (270–275, red) and the a PAS-CC linker (400–419, blue) regions
(Figure 4b, Figure 1—figure supplement 5). Overall, these interfaces are maintained in the active
state (Figure 4c), in spite of the straightening by the CC domains. Activation of sGC induces the for-
mation of an interface between b CC (355-367) and b H-NOX (33-41) (Figure 4c, purple). These resi-
dues on the b H-NOX comprise a loop located between helix aB and aC in the b H-NOX domain
which was extended away from the CC in the inactive state. The large conformational change of the
H-NOX/PAS bundle is necessary for the formation of the new interface in the active site, and thus
this interaction could be critical for stabilizing the active sGC conformation.
In the active structure, the CCs undergo a significant conformational change and rotation relative
to the CAT dimer (Figure 4d). The active state CC domains are completely extended (56 A˚ and 63
A˚ for aCC and bCC respectively in the inactive state, to 74 A˚ for both CC in the active state), as the
bend present in the inactive state moves away from the CAT domains to be in line with the C-termi-
nal portion of both CC domains. The CC conformational change upon activation twists the CC inter-
face such that the b CC helix rotates relative to the a CC by 72 degrees (Figure 4d). The dramatic
rearrangements of the H-NOX/PAS bundle leads to unbending of the CC domains, a change in their
orientations as they project from the regulatory lobe, and finally to opening of the nucleotide-bind-
ing pocket (Figure 4e). Alignment to the a CAT domain shows a clear rotation of the b CAT domain
away from a CAT domain by 40˚ (Figure 4e, left). This rotation entails the pinching together of the
base of the CC domains (Figure 4e, middle). In combination, these motions open the GTP-binding
pocket by moving the b CAT active site helix (535-545) away from the a CAT domain and into an
active conformation.
SAXS shows a distribution of inactive and active states in solution
Small angle X-ray scattering (SAXS) was used to interrogate conformational changes with and with-
out NO in solution. Experiemnts with sGC stimulators were not included as the limited solubility of
YC-1 is precludes the collection of scattering data. Size exclusion chromatography (SEC)-SAXS and
SEC-multi angle light scattering (MALS) chroma-
tograms show a symmetrical peak for both sam-
ples with little variation in radius of gyration (Rg)
and estimated MW across the peaks, indicating
sample homogeneity (Figure 5—figure supple-
ment 1).
The UV-visible absorption of the Soret band of
the heme and of the protein itself were used to
evaluate the ligation state of Ms sGC in the SAXS
experiment. The ratios of Soret band to protein
peak in the full UV-visible absorption spectra are
0.85, 0.35, and 0.20 in the unliganded, 1-NO,
and xsNO states, respectively (Figure 1b, Fig-
ure 5—figure supplement 1). The ratios of these
two peaks in the SEC-SAXS experiments were
0.77 with NO and 0.32 without NO (Figure 5—
figure supplement 1). The 432/280 ratio in the
SAXS sample without NO is less than in the full
UV-Visible spectra, indicating that the sample
Figure 3 continued
Figure supplement 7. Differential H/D Exchange values representing change in percent D by subtracting the active state from the inactive state.
DOI: https://doi.org/10.7554/eLife.50634.030
Video 2. Cryo EM Reconstruction of the Active sGC
Confromation.
DOI: https://doi.org/10.7554/eLife.50634.031
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had a slightly lower heme incorporation. The ratio for the SAXS sample with NO was lower than that
expected for 1-NO, but much larger than predicted for the xsNO ratio, indicating that the SAXS
samples were in the unliganded and 1-NO state during elution, respectively.
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Figure 4. Conformational rearrangements of Ms sGC upon activation. (a) Overlay of the inactive (transparent, gray)
and active (a - orange, b – blue) shown in two views. Rotation of the regulatory domain and CAT dimer are shown
with arrows and label with degree of rotation. Distances between the b H-NOX domain and CAT dimer are
labeled for inactive (gray) and active (black). (b) Close up view of the inactive interfaces between the b HNOX
(green), b PAS (red), and a CC (blue). (c) Closeup view of the active interfaces colored as in Figure 4b with the b
H-NOX:b CC interface in purple. (d) Overlay of the inactive (transparent) and active (colored) CC domains when
aligned to the active a CC domain. Dimensions of the CC and rotation are labeled in color for the inactive and
black for the active. (e) Three views of aligned inactive (transparent) and active (colored) CAT dimers are shown.
Direction of rotation (curved arrows) and pinching (arrows) are shown.
DOI: https://doi.org/10.7554/eLife.50634.032
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The Rg for the unliganded and 1-NO state
were 43.1 ± 0.4 and 43.8 ± 0.2 A˚, respectively,
representing an elongation of the structure (Fig-
ure 5—figure supplement 1,
Supplementary file 2 - Table S2). Additionally, the Pair-distance function (P(r)), which shows a com-
posite of the inter-atomic distances, displays a distinct shift between the unliganded and 1-NO
states in the region from ~70 to~100 A˚. This corresponds to an extension of the regulatory lobe
from catalytic lobe (Figure 5a). Shifts in the secondary peaks of the Kratky plots (Figure 5—figure
supplement 2) further suggest separation of the regulatory and catalytic lobes upon activation.
Using the inactive model obtained from cryo-EM as an initial Ca model, a rigid-body modeling
pipeline was developed to systematically explore conformational space (see Online Methods)
(Pelikan et al., 2009). A minimal ensemble search was performed over thousands of sGC conforma-
tions and corresponding scattering curves were calculated and compared to the experimental data.
The result of this minimal ensemble search confirmed the presence of a single sGC conformation
while in an inactive state (Figure 5b, Figure 5—figure supplement 3), which overlays with the inac-
tive structure with an RMSD of 2.0 A˚. The 1-NO state was best modeled as an ensemble of two
states, with the majority (72%) of the sample consistent with the inactive model (Figure 5b). How-
ever, the remainder of the sample (28%) is consistent with a more elongated conformation, one that
is in between the inactive and active state obtained by cryo-EM. The Ca RMSD of the partially active
SAXS model and the active state cryo-EM model is 13.5 A˚. This analysis shows that sGC adopts a
mixture of inactive and active conformations in the 1-NO state, suggesting that NO binding at the
heme establishes an equilibrium between these two conformational extremes (Figure 5—figure sup-
plement 3).
Discussion
The structures of the inactive and active states of full-length sGC provide detailed insight into the
molecular mechanism of activation of Ms sGC. The most unexpected feature of the inactive state of
the enzyme are the bends in the CC domains. Straightening of the bent CCs is the clearest structural
link between the regulatory and catalytic lobes during activation. Previous HDX-MS data showed a
differential exchange pattern for the CC domains, where the N-terminal portion of the a CC and the
C-terminal portion of the b CC increase in H/D exchange upon NO binding, while the C-terminal
portion of the a CC and the N-terminal portion of the b CC decrease in H/D exchange (Figure 3—
figure supplement 7) (Underbakke et al., 2014). The changes seen in HDX in the CCs near the
bend are thus consistent with the large-scale rearrangements of the CCs that we have now observed
in the cryo-EM. Furthermore, the bent portion of the CC domain is highly conserved among sGC
homologues, consistent with its centrality to allosteric communication.
The C-terminal portions of the CC domains undergo a 72˚ twist and contain a motif known as the
signaling helix (or S-helix) (Anantharaman et al., 2006). Similar to sGC, proteins with this motif con-
tain both receptor and output domains that are connected by dimeric coiled-coils. The inactive and
active sGC structures are the first full-length enzyme with a S-helix motif to be characterized. This
Video 3. Modeled Conformational Rearrangement of
the Inactive and Active States.
DOI: https://doi.org/10.7554/eLife.50634.033
Video 4. Example of conformational sampling
produced by BILBOMD (Pelikan et al., 2009).
DOI: https://doi.org/10.7554/eLife.50634.042
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Figure 5. SAXS analysis of the activation of sGC. (a) Normalized P(r) for the unliganded (black) and 1-NO (gray) states of sGC are shown together with
corresponding models of the inactive and partially extended conformations of sGC (N-terminal and C-terminal tails are omitted for clarity). The area of
each P(r) is normalized relative to the SAXS-determined molecular weights (Supplementary file 2 - Table 2). (b) Experimental (black and gray) and
theoretical (blue and red) SAXS profiles for the solution state models in the panel a. SAXS fits are shown together with the fit residuals in the below
graph.
DOI: https://doi.org/10.7554/eLife.50634.034
The following source data and figure supplements are available for figure 5:
Source data 1. Source Data for Pair Distribution plots of Ms sGC.
DOI: https://doi.org/10.7554/eLife.50634.038
Source data 2. Source Data for experimental and modeled scattering of Ms sGC.
DOI: https://doi.org/10.7554/eLife.50634.039
Figure supplement 1. Top: Small angle X-Ray scattering chromatograms with intensity (lines) and Rg (symbols) values for each frame merged across
the SEC peak.
DOI: https://doi.org/10.7554/eLife.50634.035
Figure supplement 2. Normalized Kratky plot for the inactive (black) and active state (gray) of sGC.
DOI: https://doi.org/10.7554/eLife.50634.036
Figure 5 continued on next page
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motif aligns with C-terminal part of the CC domain, part of the 72˚ twist described above (Figure 2—
figure supplement 10). It is possible that the twisting motion of these domains is a more general
mechanism of activation for proteins with S-helices.
In transitioning between the inactive and active states, the H-NOX/PAS bundle rotates 71˚ in
order for b H-NOX residues 33–41 to form an interface with residues b 355–367 of the b CC domain
(Figure 4c, purple). The aH helix of the b H-NOX domain contains the proximal histidine that binds
to the heme cofactor (Zhao et al., 1998). Crystal structures of bacterial H-NOX domains with and
without NO show a rotation in the aF helix of the b H-NOX. However, in our full-length structures,
the aF of the b H-NOX retains its interface with the b PAS and the a CC domain in both states
(Figure 4b and c). More strikingly, binding of YC-1 at a site bridging the b H-NOX and CC domain
highlights how stabilization of this contact drives CC unbending (Figure 3c). This interface corrobo-
rates specific point mutations known to decrease activity of the full-length protein; specifically, single
point mutants of b I41E in the b H-NOX domain retain basal activity but are only minimally activate
with excess NO, implying that these sGC variants are catalytically competent but not as sensitive to
stimulation as the wildtype enzyme (Underbakke et al., 2013; Baskaran et al., 2011b). The struc-
tural finding that residue Ile41 of the b H-NOX form contacts with the unbent b CC that are specific
for the active conformation explains these phenotypes. Destabilizing these contacts by mutating
Ile41 thus blocks this interface and prevents sGC from reaching the active conformation. While this
paper was under review, a cryo-EM map of activated H. sapiens sGC was reported, where the activa-
tion was achieved by using xsNO (Kang et al., 2019). This xsNO map and the xsNO + YC-1 map
reported here overlay well, except for the proposed density for YC-1. This lends support to our
assignment of the YC-1 binding site at the b H-NOX- b CC interface. These insights suggest that the
b H-NOX- b CC contact may be the most critical allosteric switch in the regulatory lobe of sGC.
While conformational changes are readily observed by comparing the two cryo-EM structures,
the SAXS implies that the 1-NO state can sample similar conformations (Figure 5a). Although only a
fraction of the population exhibits an extension, inspection of the Soret to protein UV-visible absorp-
tion indicates that the protein is in the 1-NO state. These data support the hypothesis that when the
first NO binds to the heme of the b H-NOX, sGC adopts an equilibrium between the inactive and a
partially extended conformation, with a Keq = [active]/[inactive] = [0.72]/[0.28]=0.39. This is corrobo-
rated by the activity data from the 1-NO state, which exhibits 15% of the maximal activity. The con-
formational heterogeneity observed in SAXS analysis could represent the physiological state of sGC
at basal cellular conditions.
In the absence of increased NO concentrations, sGC stimulators can maximally activate cGMP
production and are now used to treat forms of pulmonary hypertension (Koglin et al., 2002;
Follmann et al., 2013). YC-1 was present in the sample used to generate the active state reconstruc-
tion of Ms sGC, and extra density is seen near the new b H-NOX: b CC interface (Figure 3c). Distinct
changes in both resonance Raman and electron paramagnetic resonance spectroscopy signatures
for heme ligands have been detected with both YC-1 and BAY 41–2272 supporting this proposed
binding site (Derbyshire, 2008). Previously, a stimulator binding site was proposed between helices
aA and aD in the b H-NOX domain based on cross linking and NMR data (Wales et al., 2018). How-
ever, there is no density for YC-1 present in the active state reconstruction between aA and aD heli-
ces. We note that our study used YC-1 compared to IWP-854, IWP-051 and BAY 41–2272 previously
used, which could explain the difference in binding sites. Visualization of YC-1 bound to sGC is an
important development as a proof of concept that small molecule sGC stimulators can now be char-
acterized structurally.
Adenylyl cyclases (AC) catalyze a similar reaction mechanism as sGC. Mammalian membrane-
associated ACs contain two catalytic domains which form the intrapolypeptide equivalent of a heter-
odimer. The catalytic domains in active mammalian AC heterodimer rotate by 7˚ with respect to an
inactive homodimeric counterpart bound to two molecules of forskolin (Zhang et al., 1997;
Figure 5 continued
Figure supplement 3. Top: Best fit conformations for the inactive state of sGC.
DOI: https://doi.org/10.7554/eLife.50634.037
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Tesmer et al., 1997; Hurley, 1999). We observe a rotation of the sGC CAT domains about the
same axis, although the magnitude is larger for sGC, at 40˚. A full-length membrane bound AC (AC-
9) was recently solved in the active nucleotide-bound state (Qi et al., 2019). The CC domains
between the full-length active sGC and AC9 structures overlay well, consistent with a common active
geometry for GCs and ACs. The AC9 has a very different angle between the CC and CAT domains.
The rotation of the sGC regulatory lobe is sterically incompatible with the presence of a membrane,
thus by their different natures as soluble and membrane-associated enzymes, sGC and ACs must dif-
fer in the detailed modes of allosteric communication.
To date, a detailed understanding of sGC activation has been hampered by the lack of full-length
structures. The inactive and active structures in tandem with established studies lead to formation of
new hypotheses for the activation of sGC. First, activity assays with sGC truncations suggested that
direct interaction of the b H-NOX domain and the CAT dimer was responsible for sGC inhibition
(Winger and Marletta, 2005). However, the structural data shows no direct interaction between the
b H-NOX and the CAT domain in either conformation. Instead, the formation of the new b H-NOX/b
CC interface in the active state stimulates the active CAT conformation. Activation leads to a global
conformational rearrangement of the heterodimer, elongating the structure; however, only a single
equivalent of NO is required to cleave the bond between the heme Fe center and the ligating histi-
dine residue. Maximal activation of sGC involves either the binding of a second NO molecule to a
non-heme site on sGC or a small molecule stimulator stabilizing the active state (Guo et al., 2017;
Horst and Marletta, 2018).
Figure 6 depicts the proposed physiological activation sequence of sGC, where unliganded sGC
adopts a more compact conformation with bent CC domains. Upon NO binding to the heme, an
equilibrium of conformational states is established, with the partially elongated state affording about
15% of the maximal activity. Given the very tight association between NO and the heme, this repre-
sents the basal cellular activity. Finally, in the presence of either an increase in NO concentration or
sGC stimulating molecules, the completely extended, fully active state is reached and sGC reaches
maximal catalytic activity. Using these structures as a starting point, new avenues of exploration can
now be undertaken, to elucidate the molecular mechanisms of excess NO activation. Critical resi-
dues for interdomain interactions along with the proposed stimulator binding site can be character-
ized in more detail. Having resolved the two structural states of an important therapeutic target, the
structures of sGC will influence rational design of improved drugs for diseases associated with NO
signaling impairment.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation Source or reference Identifiers Additional information
Gene
(Manduca
sexta)
Ms sGC a1 Integrated
DNA Tech
nologies
Genbank:
AF062750
Uniprot: O77105
Gene
(Manduca
sexta)
Ms sGC b1 Integrated
DNA Techn
ologies
Genbank:
AF062751
Uniprot:
O77106
Strain,
strain
background
(E. coli)
XL1-Blue UC Berkeley
MacroLab
Cloning strain
Strain,
strain
background
(E. coli)
DH10-Bac UC Berkeley
MacroLab
Transp
osition Strain
Recombinant
DNA
reagent
pFastBac
(plasmid)
Thermo
Fisher
Donor Plasmid
Continued on next page
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Continued
Reagent type
(species) or
resource Designation Source or reference Identifiers Additional information
Recombinant
DNA
reagent
pFastBac_Ms
_a1_His6
This paper See Materials and
methods section
Construction of
Plasmids
Recombinant
DNA
reagent
pFastBac_
Ms_b1
This paper See Materials and
methods section
Construction of
Plasmid
Sequence-
based regent
Primers This paper See primer
table in
Materials
and
methods
Cell line
(Spodoptera
frugiperda)
SF9 cells UC Berkeley
Cell Culture
Facility
RRID:
CVCL_0549
Commercial
Assay or Kit
Cellfectin II Thermo
Fisher
Transfection reagent
Transfected
Construct
(Manduca
sexta)
bMON14272_
Ms_a1_His6
(bacmid)
This paper Transfected construct
Transfected
Construct
(Manduca
sexta)
bMON14272_
Ms_b1_His6
This paper Transfected construct
Chemical
compound,
drug
DEA NO
NOate
Cayman
Chemical
Item No:
82100
CAS:
372965-00-9
Chemical
compound,
drug
PROLI N
ONOate
Cayman
Chemical
Item No:
82145
CAS:
17894
8-42-0
Commercial
Assay or
Kit
cGMP ELISA Enzo Life
Science
ADI-901–013
Materials
All chemicals were purchased from commercial vendors and used without further purification, unless
otherwise noted. Primers and gBlocks were obtained from Integrated DNA Technologies (Coralville,
IA). Gibson Master Mix was purchased from New England Biolabs (Ipswich, MA). PrimeSTAR Max
DNA polymerase and TALON superflow resin was purchased from Takara Bio USA (Mountain View,
CA). DNA purification kits were purchased from Qiagen (Germantown, MD). ExCell-420 media,
sodium dithionite (Na2S2O4), DNAse I from bovine pancreas, b-mercaptoethanol, sodium phosphate,
dibasic (Na2HPO4), sodium carbonate (Na2CO3), potassium phosphate (K2HPO4), guanosine 5
0-tri-
phosphate sodium salt (GTP) (>95%, HPLC), and zinc acetate (Zn(CH3CO2)2) were purchased from
Millipore Sigma (Burlington, MA). 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF)
was purchased from Research Products International (Mount Prospect, IL). Isopropyl b-D-1-thiogalac-
topyranoside (IPTG), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), and the Pierce
BCA Protein Assay Kit were purchased from Thermo Fisher Scientific (Waltham, MA). Benzamidine,
sodium chloride (NaCl), magnesium chloride (MgCl2), and glycerol were purchased from VWR Life
Science (Visalia, CA). Dithiothreitol (DTT) was purchased from Bachem (Bubendorf, Switzerland).
Imidazole was purchased from Oakwood Chemical (West Columbia, SC). Vivaspin spin concentrators
were purchased from Sartorius (Concord, CA). BioSpin six desalting columns were purchased from
BioRad (Hercules, CA). Diethylamine NONOate (DEA NONOate), PROLI NONOate, diethylamintri-
amine NONOate (DETA NONOate), and YC-1 were purchased from Cayman Chemical Company
(Ann Arbor, MI). Carbon monoxide (CO,>99%) gas was purchased from Praxair Inc (Danbury, CT).
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Construction of plasmids
Manduca sexta sGC a1 (Uniprot: O77105) and b1(Uniprot: O77106) genes were purchased as
gBlocks from IDT with a C-terminal 6x His tag on the a1 gene with Golden Gate cloning sites. The
gBlocks were subcloned into a Golden Gate entry vector (gift of the Tullman-Ercek lab, Northwest-
ern University). PCR was used to add regions of homology to pFastBac (Bac-to-Bac Baculovirus
Expresion System, Thermo Fisher Scientific), and Gibson Assembly was performed to generate
pFastBac_Ms_sGC_a1_His6 and pFastBac_Ms_sGC_b1. The genes were transposed into a baculovi-
rus bacmid using DH10Bac-GFP cells. The bacmid was isolated, validated, and then transfected into
SF9 cells (Berkeley Cell Culture Facility) to generate recombinant baculovirus for both genes.
Name Sequence (5’ fi 3’) Target Purpose
oBGH130 GGAGATAATTAAAATGATAACCATCTCGC pFastBac Sequencing
oBGH131 TTTATTTGTGAAATTTGTGATGCTATTGC pFastBac Sequencing
oBGH297 CGATGGAGTACGAAGCGAATTTCGTATG Ms_a Sequencing
oBGH168 GCCTGCACGATCATCTCGGGAC Ms_b Sequencing
oBGH195 CTGCCAAGCTCCAGGAACACC ATGACGTGTCCATTCCGTCGTG Ms_a (F) Cloning
oBGH196 CCTCGAGACTGCAGGCTCTAGA TTAGTGATGGTGATGGTGATG Ms_a (R) Cloning
oBGH197 GCTCCGGGAGCGGACACC ATGTACGGGTTTGTGAACTATGCCC Ms_b (F) Cloning
oBGH198 CCCCACAAAGGCTGCCAT TTAATGGATCTTCCTGGTGAGGAACCAG Ms_b (R) Cloning
oBGH199 CATCACCATCACCATCACTAATCTAGAGCCTGCAGTCTCGAGG pFastBac (F) Cloning
oBGH200 CACGACGGAATGGACACGTCATGGTGTTCCTGGAGCTTGGCAG pFastBac (R) Cloning
oBGH201 CTGGTTCCTCACCAGGAAGATCCATTAAATGGCAGCCTTTGTGGGG pFastBac (F) Cloning
oBGH202 GGGCATAGTTCACAAACCCGTACATGGTGTCCGCTCCCGGAGC pFastBac (R) Cloning
Inactive State Maximally Active
α H-NOX
α CAT
α CC
α PAS
ȕH-NOX
ȕPAS
ȕCC
ȕCAT
N O
1-NO State
GTP cGMP
N O or
N O or
72%
Inactive
28%
Partially Extended
GTP cGMP
Figure 6. Model for conformational rearrangement upon sGC activation. Schematic of the sGC activation pathway. sGC adopts a bent CC
conformation after formation of the holoenzyme. Upon the addition of NO an equilibrium exists between the inactive and partially extended states,
conferring partial activation of sGC. When excess NO enters the cell or the addition of a stimulator compound, the equilibrium shifts to the active state,
allowing for an open CAT dimer conformation and maximal activity.
DOI: https://doi.org/10.7554/eLife.50634.040
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Protein expression and purification
SF9 cells were maintained in monolayer and in suspension in ExCell-420 media at 27˚C (cells were
shaken at 135 rpm). The recombinant baculovirus was amplified until the titer was greater than
1  108 cfu/mL. Five liters of SF9 cells were coinfected with 50 mL of amplified virus per liter and
allowed to express for 72 hr. Cells were spun down at 4300 g for 20 min, snap frozen in liquid nitro-
gen, and stored at –80˚C.
The following steps were performed at 4˚C. Cell pellets were thawed in ice water and resus-
pended in lysis buffer: Buffer A (50 mM Na2HPO4, pH 8.0, 200 mM NaCl, 1 mM imidazole, 1 mM
benzamidine, 5% (v/v) glycerol, 0.22 mm filtered) supplemented with 10 mM benzamidine, 1 mM
AEBSF, 0.5 mg/mL bovine DNAse I, and 5 mM b-mercaptoethanol. Cells were lysed in a bead beater
(BioSpec) with 0.5 mm glass beads. The resulting cell lysate was clarified by spinning at 4300 g for 5
min, followed by spinning at 158,000 g for 2 hr (Ti45 rotor, Beckman Coulter). The lysate was passed
through a column containing 2 mL TALON superflow at 0.5 mL/min, and the flow-through was col-
lected. The column was washed with 15 column volumes of Buffer A supplemented with 5 mM b-
mercaptoethanol at 0.5 mL/min. The protein was eluted with 10 CV of Buffer B (50 mM Na2HPO4,
pH 8.0, 200 mM NaCl, 150 mM imidazole, 1 mM benzamidine, 5% (v/v) glycerol, 0.22 mm filtered)
supplemented with 5 mM b- mercaptoethanol. Fractions with yellow color were concentrated to <2
mL using a 30,000 molecular weight cutoff spin concentrator, supplemented with 5 mM DTT and 5
mM EDTA, and stored overnight. Next, the sample was diluted to 9 mL with Buffer C (25 mM trie-
thanolamine, 25 mM NaCl, 5 mM DTT, 5% (v/v) glycerol, 0.22 mm filtered), and applied to a POROS
HQ2 anion exchange column (Thermo Fisher Scientific). The column was washed with 3 CV of Buffer
C, and then a gradient to 50% Buffer D (25 mM triethanolamine, 750 mM NaCl, 5 mM DTT, 5% (v/v)
glycerol, 0.22 mm filtered) was established over 17 CV at 0.5 mL/min. Fractions with purified sGC
were concentrated to 5–50 mM and stored in liquid nitrogen. A typical yield for this expression and
purification procedure is 100 mg sGC per liter of insect cells.
Intact protein mass spectrometry
Purified proteins were buffer-exchanged into 25 mM HEPES, pH 7.5, 25 mM NaCl using three
rounds of dilution and concentrations in a Vivaspin 500 (30,000 MWCO) spin concentrator. Samples
were filtered with a 0.22 mM spin filter (Millipore). The final sample concentration was approximately
5 mM. Samples were separated with an Agilent 1200 series high-pressure liquid chromatography
(HPLC) system over a ProSwift column (ThermoFisher Scientific), and subsequently analyzed by an
Agilent 6224 time-of-flight (TOF) mass spectrometer with a Turbospray ion source in positive ion
mode.
Absorption spectroscopy
Samples were reduced in an anaerobic glove bag (Coy) with 5 mM Na2S2O4 for 15 min, and then
desalted with a BioSpin6 column equilibrated with Buffer E (50 mM HEPES, pH 7.5, 150 mM NaCl,
5% (v/v) glycerol, 0.22 mm filtered). CO-saturated buffer (950 mM CO) was prepared by sparging 3
mL of anaerobic Buffer E for 15 min in a Reacti-Vial (Thermo Fisher Scientific). CO was added to the
sample to achieve a final concentration of 425 mM. Nitric oxide was added to a concentration of 500
mM by addition of DEA NONOate, based on 1.5 moles of NO released per mole of NONOate. Pro-
tein-ligand complexes were incubated for 15 min at room temperature to establish equilibrium, and
no further spectral changes were observed after this time. Samples were placed in a septum-sealed
1 cm pathlength quartz cuvette inside the glove bag, and UV–Vis spectra were recorded on a Cary
300 spectrophotometer (Agilent Technologies).
Activity assays and quantification
Steady-state kinetics for Ms sGC were measured by quantifying the amount of cGMP produced in
duplicate endpoint activity assays, performed in at least biological triplicate. Samples were reduced
in an anaerobic glove bag with 5 mM Na2S2O4 for 15 min, and then desalted with a BioSpin6 column
equilibrated with Buffer E. Ms sGC with 1-NO and xsNO were prepared by first adding PROLI NON-
Oate to 50 mM, based on 2 moles of NO released per mole of PROLI NONOate. This sample was
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then buffer exchanged into Buffer E through a BioSpin6 column to generate the 1-NO state. To gen-
erate the xsNO state, PROLI NONOate was added back to a portion of the 1-NO sample and
allowed to equilibrate for 5 min. YC-1 was added from a 100x stock solution in DMSO to a final con-
centration of 150 mM (final DMSO concentration 1%). The protein concentration was determined
using the reduced heme Soret peak at 433 nm (149,000 M–1 cm–1) (Hu et al., 2008). Protein concen-
tration was adjusted after desalting the excess NO by comparing the A280 peaks to the unliganded
protein. Activity assays were conducted at 25˚C and pH 7.5 in Buffer D, supplemented with 5 mM
DTT and 5 mM MgCl2. Reactions were initiated with 2 mM GTP and timepoints from were quenched
with 125 mM Zn(CH3CO2)2, followed by 125 mM Na2(CO3) to adjust the pH to 10.5. Samples were
frozen at –80˚C until quantification. Quenched assays were thawed, and the zinc precipitate was
spun down for 10 min at 23,150 g. The reactions were diluted by one to three orders of magnitude,
and the cGMP was quantified in duplicate using an extracellular cGMP Enzyme Linked Immunosor-
bent Assay, following the manufacturer’s instructions (Enzo Life Sciences). Concentrations of cGMP
were determined from a standard curve, generated over 0.16–500 pmol/mL. Initial rates were calcu-
lated from the linear phase of the time course, where 5–10% of the GTP substrate was consumed.
The experiment was repeated at least three times to ensure reproducibility.
Cryo-EM sample preparation and data collection
Samples were reduced in an anaerobic glove bag with 5 mM Na2S2O4 for 15 min, and then desalted
with a BioSpin6 column equilibrated with Buffer F (25 mM triethanolamine, pH 7.5, 25 mM NaCl, 5
mM DTT, 0.22 mM filtered). The inactive protein sample was diluted after thawing from a single fro-
zen stock to ~2–4 mM in 1–3% trehalose. The sample (3.5 mL) was applied to glow discharged UltrA-
Ufoil 2/2 200 mesh gold grids (Quantifoil) and plunge-frozen using a vitrobot Mark IV (Thermo
Fischer). Blotting was performed under 100% humidity with zero blot force for 3–6 s. sGC was dis-
persed in vitreous ice which displayed clear contrast transfer function information (Figure 2—figure
supplement 1a. Active sample was prepared in a similar manner, but 500 mM NO (from DEA NON-
Oate) and 150 mM YC-1 were added (Figure 3—figure supplement 1a-b).
Grids were screened and imaged on a Talos Arctica (Thermal Fischer) operated at 200 kV. Com-
plete imaging conditions are described in Supplementary file 1. Micrographs were collected at
36,000X nominal magnification on a K3 direct electron detector (Gatan) in super-resolution counted
mode at 0.5685 a˚/pix. Serial EM was used for automated image shift data collection of 2841 and
9330 movies for the inactive and active sample, respectively. Movies were taken in 100 ms frames,
totaling an electron dose of 60 electrons per movie.
Cryo-EM data processing
Inactive sGC movies were drift-corrected, gain-corrected, and binned to 1.137 A˚/pix in 7  5
patches using MotionCor2 (Zheng et al., 2017). Micrographs were CTF-corrected using CTFFIND4
and single particles were manually picked for initial 2D classification within Relion 3.0 (Rohou and
Grigorieff, 2015; Scheres, 2012; Nakane et al., 2018). Class averages representing the full-length
complex (Figure 2—figure supplement 1c) were used for template picking with Relion autopicker,
resulting in 675,956 particles. Particles were imported into Cryosparc2 and pruned using 2D classifi-
cation and 3D ab initio classification (Punjani et al., 2017). Initial 2D classification yielded a large
number of falsely picked background particles and particles which represented broken sGC dimers.
We suspect the background particles are due to the size of the complex, while the broken particles
likely stem from damage at the air-water interface (Figure 2—figure supplement 1c). These poor
class averages were removed from further processing steps. In total, 59,165 final particles were
refined using non-uniform refinement with default parameters (Figure 2—figure supplement 1b).
Active sGC movies were binned to 2.274 A˚/pix before template-free Laplacian picking for initial par-
ticle selection (Nakane et al., 2018). Micrographs were manually cleaned by visual inspection and
FFT quality. Initial single particles were pruned using iterative 2D and 3D techniques (Figure 3—fig-
ure supplement 1b, c), as described above for the inactive state. Similarly, many of the initial picked
particles were background or broken in the Active dataset (Figure 3—figure supplement 1c)
Blurred density at low thresholds was seen in a predicted region for the alpha-HNOX but did not
resolve during processing and was masked away during the final reconstruction. Of note, both Inac-
tive and Active datasets underwent exhaustive processing schemes, including Bayesian polishing,
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multibody refinement and focused classification, none of which improved the resolution or showed
evidence of multiple conformations in a single dataset.
Model building
Homology models for each domain were built using Phyre2 and correspond to the following PDB
entries: a H-NOX (2O0C), a PAS (4GJ4), a CC (3HLS), a CAT (3UVJ), b H-NOX (2O0C), b PAS
(4GJ4), b CC (3HLS), b CAT (2WZ1) (Kelley et al., 2015). Domains (with side chains removed) were
rigid-body docked into the inactive reconstruction using the fit_in_map function of Chimera
(Pettersen et al., 2004). Clear density for heme in the b H-NOX domain enabled clear distinction of
the two H-NOX domains. Linkers between the H-NOX and PAS domains are missing in the density,
likely due to flexibility, and were left out of the model (a 238–278 and b184–206). Initial placement
of the CAT dimer was based on a significant extension in the sequence of the a CAT C-terminus,
which is visible as unmodeled density. Continuous density from the CAT dimer enabled assignment
of the CC and PAS domains. The linker region between the PAS domains and the CC were manually
modeled in COOT based on secondary structure predictions from PSIPRED (Emsley et al., 2010;
Vynne, 1997). Refinement using iterative rounds of phenix.real_space_refine and inspection in
COOT led to the final carbon back bone trace of the inactive state. Active state modeling was based
on rigid-body fitting of domains based on the inactive state. Helical density was apparent through-
out the structure (with the exception of the a H-NOX, as mentioned above). Linker regions between
domains were corrected with COOT and phenix.real_space_refine. Final model idealization was car-
ried out using phenix.model_idealization and validated using Molprobity (Chen et al., 2010).
Small-angle X-ray scattering in-line with size-exclusion chromatography
(SEC-SAXS)
Samples were reduced in an anaerobic glove bag with 5 mM Na2S2O4 for 15 min, concentrated to
60 mL at 50 mM (~7.5 mg/mL), and then three rounds of dialysis were performed in Buffer G (50 mM
KH2PO4, pH 7.4, 150 mM NaCl, 2% glycerol). The activated sample was prepared with 500 mM NO
(from DEA NONOate). The samples were sealed and run within 3 hr of being prepared; samples did
not undergo freeze–thaw after the sample was prepared (the protein was freeze–thawed once after
purification for initial storage).
In situ sample purification was accomplished through SEC to isolate well-folded proteins from
aggregates and other impurities immediately before exposure to synchrotron X-ray radiation using a
custom designed flow cell. SEC-SAXS was collected at the SIBYLS beamline (bl12.3.1) at the
Advanced Light Source at Lawrence Berkeley National Laboratory, Berkeley, California
(Classen et al., 2010; Classen et al., 2013). X-ray wavelength was set at l = 1.127 A˚ and the sam-
ple-to-detector distance was 2105 mm, as determined by silver behenate calibration, resulting in
scattering vectors, q, ranging from 0.01 A˚–1 to 0.4 A˚–1. The scattering vector is defined as
q = 4psinq/l, where 2q is the scattering angle. Data was collected using a Dectris PILATUS3  2M
detector at 20˚C and processed as previously described (Dyer et al., 2014; Hura et al., 2009).
Briefly, a custom-made SAXS flow cell was directly coupled with an Agilent 1260 Infinity HPLC sys-
tem using a Shodex KW-803 column. The column was equilibrated with running Buffer E with a flow
rate of 0.5 mL/min for inactive sGC and 0.55 mL/min for activated sGC. To achieve activation condi-
tions, the buffer was continuously sparged with nitrogen gas and the column was equilibrated for at
least 2 hr to maintain an anaerobic environment. Several NONOates with various half-lives were
added to the running buffer to achieve activation of sGC. These NONOates include DEA NONOate
and DETA NONOate, which spontaneously release NO with half-lives of 16 min and 56 hr, respec-
tively. Each sample was run through the SEC-SAXS system and 3 s X-ray exposures were collected
continuously over the 30 min elution. The SAXS frames recorded prior to the protein elution peak
were used to correct all other frames. The corrected frames were investigated by radius of gyration
Rg derived by the Guinier approximation I(q)=I(0) exp(–q
2Rg
2/3) with the limits q*Rg <1.3 (Figure 5—
figure supplement 2). The elution peak was mapped by comparing the integral of ratios to back-
ground and Rg relative to the recorded frame using the program SCA˚TTER (Figure 5—figure sup-
plement 1).
The frames in the regions of least Rg variation were averaged and merged in SCA˚TTER to pro-
duce the highest signal-to-noise SAXS curves. These merged SAXS curves were used to generate
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the Guinier plots, volumes-of-correlation (Vc), pair distribution functions, P(r), and normalized Kratky
plots. The Guinier plot indicated an aggregation-free state of the protein (Figure 5—figure supple-
ment 2). The P(r) function was used to determine the maximal dimension of the macromolecule
(Dmax) and estimate inter-domain distances (Figure 4A) (Putnam et al., 2007). P(r) functions were
normalized based on the molecular weight (MW) of the assemblies, as determined by the calculated
Vc (Rambo and Tainer, 2013).
Eluent was subsequently split (4 to 1) between the SAXS line and a multiple wavelength detector
(UV-vis), set to 432 and 280 nm, multi-angle light scattering (MALS), and refractometer. The ratios of
the protein (280 nm) and Soret band (432 nm) of the heme from SEC were used to evaluate the liga-
tion state of Ms sGC upon NO binding (Figure 5—figure supplement 1). MALS experiments were
performed using an 18-angle DAWN HELEOS II light scattering detector connected in tandem to an
Optilab refractive index concentration detector (Wyatt Technology). System normalization and cali-
bration was performed with bovine serum albumin using a 60 mL sample at 10 mg/mL in the same
SEC running buffer and a dn/dc value of 0.185 and 0.15 mL/g for inactive and active sGC respec-
tively. The MALS data was used to compliment the MWs calculated by the SAXS analysis and, being
furthest downstream, the MALS peaks were used to align the SAXS and UV-vis peaks along the
x-axis (elution volume in mL/min) to compensate for fluctuations in timing and band broadening (Fig-
ure 5—figure supplement 1). UV–vis data was integrated using Agilent Chemstation software and
baseline corrected using Origin 9.1 (Figure 5—figure supplement 1). MALS and differential refrac-
tive index data was analyzed using Wyatt Astra seven software to monitor the homogeneity of the
sample molecular weights across the elution peak, complementing the SEC-SAXS signal validation
(Figure 5—figure supplement 1).
Solution structure modeling
The cryo-EM refined crystal structure for inactive sGC was used to build an initial atomistic model;
all missing loops and terminal residues were added using MODELLER (Fiser et al., 2000). A pur-
pose-designed rigid body modeling pipeline was applied to the completed structure using BIL-
BOMD to systematically explore conformational space for both the inactive and activated states of
sGC (Video 4) (Pelikan et al., 2009). To obtain an inactive state model, the a H-NOX domain and
both a terminal tails were moved, then all a and b domains were moved by allowing flexibility at the
hinge region where the CCs meet the CAT domains, while holding the CAT domains fixed and still
permitting flexibility of the terminal tails. This was then used to generate the 1-NO state model by
moving the same regions as the inactive state in reverse order. Theoretical SAXS curves were pro-
duced by FOXS (Schneidman-Duhovny et al., 2010; Schneidman-Duhovny et al., 2013). Each
model generated through BILBOMD as compared to the experimental SAXS profiles to assess the
goodness of fit. Multistate model ensembles for activated sGC were determined using MultiFOXS
(Schneidman-Duhovny et al., 2016).
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